Thursday, June 26, 2014
2 pm PDT, 3 pm MDT, 4 CDT, 5 pm EDT
Call in to (516) 590-0362 to listen by phone and ask questions or
What is the latest in ALS therapy and innovation? ALS expert Dr. Merit Cudkowicz, MD, MSc of Massachusetts General Hospital will join us for our very first ALS Crowd show to give patients an update on the very latest research and findings for ALS patients. This new series is created to connect ALS patients with the ALS research community, to educate and empower them to make educated choices about their care. Listen in to this important and inagural show.
Dr. Merit Cudkowicz, MD, MSc, is the Chief of the Neurology Service, Director of the Amyotrophic Lateral Sclerosis Clinic and Co-Director of the Neuromuscular Division at Massachusetts General Hospital. She is the Julianne Dorn Professor of Neurology at Massachusetts General Hospital, at Harvard Medical School. Dr. Cudkowicz completed medical training at the Health Science and Technology program of Harvard Medical School, and she was a resident in Neurology at MGH. She obtained a Master’s degree in Clinical Epidemiology from the Harvard School of Public Health.
Dr. Cudkowicz’s research and clinical activities are dedicated to the study and treatment of patients with neurodegenerative disorders, in particular amyotrophic lateral sclerosis (ALS). Dr. Cudkowicz directs the MGH ALS clinic and the Neurology Clinical Trials Unit . She is one of the founders and co-directors of the Northeast ALS Consortium (NEALS), a group of 92 clinical sites in the United States and Canada dedicated to performing collaborative academic led clinical trials in ALS. In conjunction with the NEALS consortium, she planned and completed 7 multi-center clinical trials in ALS and is currently leading three new trials in ALS. Dr. Cudkowicz received the American Academy of Neurology 2009 Sheila Essay ALS award. She is actively mentoring young neurologists in clinical investigation. Dr. Cudkowicz is on the Research Council of the American Acadenmy of Neurology and the medical advisory boards for the Muscular Dystrophy Association.